Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

A novel GNRHR gene mutation causing congenital hypogonadotrophic hypogonadism in a Brazilian kindred.

Correa-Silva SR, Fausto JDS, Kizys MML, Filipelli R, Marco Antonio DS, Oku AY, Furuzawa GK, Orchard EVH, Costa-Barbosa FA, Mitne-Neto M, Dias-da-Silva MR.

J Neuroendocrinol. 2018 Dec;30(12):e12658. doi: 10.1111/jne.12658. Epub 2018 Dec 19.

PMID:
30415482
2.

Perceptions and experiences of childhood vaccination communication strategies among caregivers and health workers in Nigeria: A qualitative study.

Oku A, Oyo-Ita A, Glenton C, Fretheim A, Ames H, Muloliwa A, Kaufman J, Hill S, Cliff J, Cartier Y, Owoaje E, Bosch-Capblanch X, Rada G, Lewin S.

PLoS One. 2017 Nov 8;12(11):e0186733. doi: 10.1371/journal.pone.0186733. eCollection 2017.

3.

Stakeholder perceptions of communication about vaccination in two regions of Cameroon: A qualitative case study.

Ames H, Njang DM, Glenton C, Fretheim A, Kaufman J, Hill S, Oku A, Cliff J, Cartier Y, Bosch-Capblanch X, Rada G, Muloliwa AM, Oyo-Ita A, Kum AP, Lewin S.

PLoS One. 2017 Aug 31;12(8):e0183721. doi: 10.1371/journal.pone.0183721. eCollection 2017.

4.

Identification of preliminary core outcome domains for communication about childhood vaccination: An online Delphi survey.

Kaufman J, Ryan R, Lewin S, Bosch-Capblanch X, Glenton C, Cliff J, Oyo-Ita A, Muloliwa AM, Oku A, Ames H, Rada G, Cartier Y, Hill S.

Vaccine. 2018 Oct 22;36(44):6520-6528. doi: 10.1016/j.vaccine.2017.08.027. Epub 2017 Aug 20.

5.

Development and validation of a variant detection workflow for BRCA1 and BRCA2 genes and its clinical application based on the Ion Torrent technology.

Buzolin AL, Moreira CM, Sacramento PR, Oku AY, Fornari ARDS, Antonio DSM, Quaio CRDAC, Baratela WR, Mitne-Neto M.

Hum Genomics. 2017 Jun 26;11(1):14. doi: 10.1186/s40246-017-0110-x.

6.

Using the COMMVAC taxonomy to map vaccination communication interventions in Mozambique.

Muloliwa AM, Cliff J, Oku A, Oyo-Ita A, Glenton C, Ames H, Kaufman J, Hill S, Cartier Y, Bosch-Capblanch X, Rada G, Lewin S.

Glob Health Action. 2017;10(1):1321313. doi: 10.1080/16549716.2017.1321313.

7.

The comprehensive 'Communicate to Vaccinate' taxonomy of communication interventions for childhood vaccination in routine and campaign contexts.

Kaufman J, Ames H, Bosch-Capblanch X, Cartier Y, Cliff J, Glenton C, Lewin S, Muloliwa AM, Oku A, Oyo-Ita A, Rada G, Hill S.

BMC Public Health. 2017 May 10;17(1):423. doi: 10.1186/s12889-017-4320-x.

8.

Childhood vaccination communication outcomes unpacked and organized in a taxonomy to facilitate core outcome establishment.

Kaufman J, Ryan R, Glenton C, Lewin S, Bosch-Capblanch X, Cartier Y, Cliff J, Oyo-Ita A, Ames H, Muloliwa AM, Oku A, Rada G, Hill S.

J Clin Epidemiol. 2017 Apr;84:173-184. doi: 10.1016/j.jclinepi.2017.02.007. Epub 2017 Feb 24.

9.

Factors affecting the implementation of childhood vaccination communication strategies in Nigeria: a qualitative study.

Oku A, Oyo-Ita A, Glenton C, Fretheim A, Eteng G, Ames H, Muloliwa A, Kaufman J, Hill S, Cliff J, Cartier Y, Bosch-Capblanch X, Rada G, Lewin S.

BMC Public Health. 2017 Feb 15;17(1):200. doi: 10.1186/s12889-017-4020-6.

10.

Patient outcomes following after-hours and weekend admissions for cardiovascular disease in a tertiary hospital in Calabar, Nigeria.

Ansa V, Otu A, Oku A, Njideoffor U, Nworah C, Odigwe C.

Cardiovasc J Afr. 2016 Sep/Oct 23;27(5):328-332. doi: 10.5830/CVJA-2016-025. Epub 2016 Apr 12.

11.

Calmodulin EF-hand peptides as Ca2+ -switchable recognition tags.

Oku A, Imanishi M, Noshiro D, Murayama T, Takeuchi T, Nakase I, Futaki S.

Biopolymers. 2017 Jan;108(1). doi: 10.1002/bip.22937.

PMID:
27554421
12.

An Assessment of Mental Health Status of Undergraduate Medical Trainees in the University of Calabar, Nigeria: A Cross-Sectional Study.

Oku A, Oku O, Owoaje E, Monjok E.

Open Access Maced J Med Sci. 2015 Jun 15;3(2):356-62. doi: 10.3889/oamjms.2015.068. Epub 2015 Jun 10.

13.

Communication strategies to promote the uptake of childhood vaccination in Nigeria: a systematic map.

Oku A, Oyo-Ita A, Glenton C, Fretheim A, Ames H, Muloliwa A, Kaufman J, Hill S, Cliff J, Cartier Y, Bosch-Capblanch X, Rada G, Lewin S.

Glob Health Action. 2016 Feb 12;9:30337. doi: 10.3402/gha.v9.30337. eCollection 2016.

14.

Mapping how information about childhood vaccination is communicated in two regions of Cameroon: What is done and where are the gaps?

Ames H, Njang DM, Glenton C, Fretheim A, Kaufman J, Hill S, Oku A, Cliff J, Cartier Y, Bosch-Capblanch X, Rada G, Muloliwa A, Oyo-Ita A, Lewin S.

BMC Public Health. 2015 Dec 21;15:1264. doi: 10.1186/s12889-015-2557-9.

15.

Outcomes mapping study for childhood vaccination communication: too few concepts were measured in too many ways.

Kaufman J, Ryan R, Bosch-Capblanch X, Cartier Y, Cliff J, Glenton C, Lewin S, Rada G, Ames H, Muloliwa AM, Oku A, Oyo-Ita A, Hill S.

J Clin Epidemiol. 2016 Apr;72:33-44. doi: 10.1016/j.jclinepi.2015.10.003. Epub 2015 Oct 16. Review.

16.

Mistreatment among undergraduate medical trainees: A case study of a Nigerian medical school.

Oku AO, Owoaje ET, Oku OO, Monjok E.

Niger J Clin Pract. 2014 Nov-Dec;17(6):678-82. doi: 10.4103/1119-3077.144377.

17.

The use of the partograph in labor monitoring: a cross-sectional study among obstetric caregivers in General Hospital, Calabar, Cross River State, Nigeria.

Asibong U, Okokon IB, Agan TU, Oku A, Opiah M, Essien EJ, Monjok E.

Int J Womens Health. 2014 Oct 13;6:873-80. doi: 10.2147/IJWH.S49188. eCollection 2014.

18.

An evaluation of the knowledge and utilization of the partogragh in primary, secondary, and tertiary care settings in calabar, South-South Nigeria.

Okokon IB, Oku AO, Agan TU, Asibong UE, Essien EJ, Monjok E.

Int J Family Med. 2014;2014:105853. doi: 10.1155/2014/105853. Epub 2014 Sep 14.

19.
20.

Prevalence and determinants of adherence to HAART amongst PLHIV in a tertiary health facility in south-south Nigeria.

Oku AO, Owoaje ET, Ige OK, Oyo-Ita A.

BMC Infect Dis. 2013 Aug 30;13:401. doi: 10.1186/1471-2334-13-401.

21.

MGAT2 deficiency ameliorates high-fat diet-induced obesity and insulin resistance by inhibiting intestinal fat absorption in mice.

Tsuchida T, Fukuda S, Aoyama H, Taniuchi N, Ishihara T, Ohashi N, Sato H, Wakimoto K, Shiotani M, Oku A.

Lipids Health Dis. 2012 Jun 14;11:75. doi: 10.1186/1476-511X-11-75.

22.

Reduction of renal transport maximum for glucose by inhibition of NA(+)-glucose cotransporter suppresses blood glucose elevation in dogs.

Ueta K, Yoneda H, Oku A, Nishiyama S, Saito A, Arakawa K.

Biol Pharm Bull. 2006 Jan;29(1):114-8.

23.

Long-term treatment with the Na+-glucose cotransporter inhibitor T-1095 causes sustained improvement in hyperglycemia and prevents diabetic neuropathy in Goto-Kakizaki Rats.

Ueta K, Ishihara T, Matsumoto Y, Oku A, Nawano M, Fujita T, Saito A, Arakawa K.

Life Sci. 2005 Apr 22;76(23):2655-68.

PMID:
15792833
24.

LDA-catalyzed cycloisomerization of 2-(2-propynyloxy)ethyl iodides leading to 3-(iodomethylene)tetrahydrofurans.

Harada T, Muramatsu K, Fujiwara T, Kataoka H, Oku A.

Org Lett. 2005 Mar 3;7(5):779-81.

PMID:
15727439
25.
26.

[3 + 2] Cycloreversion of bicyclo[m.3.0]alkan-3-on-2-yl-1-oxonium ylides to alkenyloxyketenes. Stereospecific aspect.

Oku A, Sawada Y, Schroeder M, Higashikubo I, Yoshida T, Ohki S.

J Org Chem. 2004 Feb 20;69(4):1331-6.

PMID:
14961687
27.

Enantioselective Lewis acid-catalyzed Mukaiyama-Michael reactions of acyclic enones. Catalysis by allo-threonine-derived oxazaborolidinones.

Wang X, Adachi S, Iwai H, Takatsuki H, Fujita K, Kubo M, Oku A, Harada T.

J Org Chem. 2003 Dec 26;68(26):10046-57.

PMID:
14682699
28.

Carbon-carbon bond formation reaction of ethereal oxonium ylides via metal-enolate intermediates.

Sawada Y, Mori T, Oku A.

J Org Chem. 2003 Dec 26;68(26):10040-5.

PMID:
14682698
29.
31.

Inhibition of gastric inhibitory polypeptide signaling prevents obesity.

Miyawaki K, Yamada Y, Ban N, Ihara Y, Tsukiyama K, Zhou H, Fujimoto S, Oku A, Tsuda K, Toyokuni S, Hiai H, Mizunoya W, Fushiki T, Holst JJ, Makino M, Tashita A, Kobara Y, Tsubamoto Y, Jinnouchi T, Jomori T, Seino Y.

Nat Med. 2002 Jul;8(7):738-42. Epub 2002 Jun 17.

PMID:
12068290
32.

Beneficial effect of T-1095, a selective inhibitor of renal Na+-glucose cotransporters, on metabolic index and insulin secretion in spontaneously diabetic GK rats.

Nunoi K, Yasuda K, Adachi T, Okamoto Y, Shihara N, Uno M, Tamon A, Suzuki N, Oku A, Tsuda K.

Clin Exp Pharmacol Physiol. 2002 May-Jun;29(5-6):386-90.

PMID:
12010180
33.

Normalization of cytoplasmic calcium response in pancreatic beta-cells of spontaneously diabetic GK rat by the treatment with T-1095, a specific inhibitor of renal Na+-glucose co-transporters.

Yasuda K, Okamoto Y, Nunoi K, Adachi T, Shihara N, Tamon A, Suzuki N, Mukai E, Fujimoto S, Oku A, Tsuda K, Seino Y.

Horm Metab Res. 2002 Apr;34(4):217-21.

PMID:
11987033
34.

Novel Homologation Reaction of Arylzincates Bearing a Leaving Group at the Ortho and Meta Positions.

Harada T, Chiba M, Oku A.

J Org Chem. 1999 Oct 29;64(22):8210-8213.

PMID:
11674738
35.
36.

Asymmetric Mukaiyama-Michael addition of acyclic enones catalyzed by allo-threonine-derived B-aryloxazaborolidinones.

Harada T, Iwai H, Takatsuki H, Fujita K, Kubo M, Oku A.

Org Lett. 2001 Jun 28;3(13):2101-3.

PMID:
11418059
38.

Inhibitory effect of hyperglycemia on insulin-induced Akt/protein kinase B activation in skeletal muscle.

Oku A, Nawano M, Ueta K, Fujita T, Umebayashi I, Arakawa K, Kano-Ishihara T, Saito A, Anai M, Funaki M, Kikuchi M, Oka Y, Asano T.

Am J Physiol Endocrinol Metab. 2001 May;280(5):E816-24.

39.

Tetrahydroquinolizinium ylides: preparation and 1,3-dipolar cycloaddition.

Kostik EI, Abiko A, Oku A.

J Org Chem. 2001 Mar 9;66(5):1638-46.

PMID:
11262108
40.

Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2.

Ohashi R, Tamai I, Nezu Ji J, Nikaido H, Hashimoto N, Oku A, Sai Y, Shimane M, Tsuji A.

Mol Pharmacol. 2001 Feb;59(2):358-66.

PMID:
11160873
41.

Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na(+)-glucose cotransporter inhibitor T-1095.

Arakawa K, Ishihara T, Oku A, Nawano M, Ueta K, Kitamura K, Matsumoto M, Saito A.

Br J Pharmacol. 2001 Jan;132(2):578-86.

42.

Antihyperglycemic effect of T-1095 via inhibition of renal Na+-glucose cotransporters in streptozotocin-induced diabetic rats.

Oku A, Ueta K, Arakawa K, Kano-Ishihara T, Matsumoto M, Adachi T, Yasuda K, Tsuda K, Saito A.

Biol Pharm Bull. 2000 Dec;23(12):1434-7.

PMID:
11145172
43.

Correction of hyperglycemia and insulin sensitivity by T-1095, an inhibitor of renal Na+-glucose cotransporters, in streptozotocin-induced diabetic rats.

Oku A, Ueta K, Arakawa K, Kano-Ishihara T, Matsumoto T, Adachi T, Yasuda K, Tsuda K, Ikezawa K, Saito A.

Jpn J Pharmacol. 2000 Nov;84(3):351-4.

44.

Molecular and functional characterization of organic cation/carnitine transporter family in mice.

Tamai I, Ohashi R, Nezu JI, Sai Y, Kobayashi D, Oku A, Shimane M, Tsuji A.

J Biol Chem. 2000 Dec 22;275(51):40064-72.

45.

T-1095, a renal Na+-glucose transporter inhibitor, improves hyperglycemia in streptozotocin-induced diabetic rats.

Adachi T, Yasuda K, Okamoto Y, Shihara N, Oku A, Ueta K, Kitamura K, Saito A, Iwakura I, Yamada Y, Yano H, Seino Y, Tsuda K.

Metabolism. 2000 Aug;49(8):990-5.

PMID:
10954015
46.

Tandem Cyclization of Alkynylmetals Bearing a Remote Leaving Group via Cycloalkylidene Carbenes.

Harada T, Fujiwara T, Iwazaki K, Oku A.

Org Lett. 2000 Jun 29;2(13):1855-1857.

PMID:
10891175
47.

Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family.

Tamai I, Nezu J, Uchino H, Sai Y, Oku A, Shimane M, Tsuji A.

Biochem Biophys Res Commun. 2000 Jun 24;273(1):251-60.

PMID:
10873595
48.
49.
50.

Supplemental Content

Support Center